Breaking Business News | Breaking business news AM | Breaking Business News PM

What the phase 1 trials of the first COVID-19 vaccine really mean

23 May 2020

What we know, what we don’t know, and what’s next.

Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase 1 trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on Wall Street.

Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.